| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8234279 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 7 Pages |
Abstract
Lower levels of fatigue at baseline and completion of CRT were significant predictors of pathologic tumor response gauged by TDS, suggesting that symptom burden may be a surrogate for tumor burden. The relationship between symptom burden and circulating cytokines merits evaluation to characterize the molecular basis of this phenomenon.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Hee Chul M.D., Nora A. M.D., Tito R. Ph.D., Edward H. M.D., Saroj M.D., Mandeep M.D., Yiqun M.A., Marc E. M.D., Christopher H. M.D., Prajnan M.D., Xin Shelley M.D., Charles S. Ph.D., Sunil M.D.,